Lesley Wiltshire

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study.

FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study.

Journal: Lung

Published: June 12, 2026

Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.

Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.

Journal: Chest

Published: March 31, 2026

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.

Journal: ERJ open research

Published: February 18, 2026

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

Journal: The European respiratory journal

Published: January 19, 2026

Monocyte Chemotactic Factors in the Airways of Patients With Mild Asthma Before and After an Allergen Challenge.

Monocyte Chemotactic Factors in the Airways of Patients With Mild Asthma Before and After an Allergen Challenge.

Journal: Allergy

Published: August 29, 2025

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial.

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial.

Journal: The European respiratory journal

Published: July 28, 2025

Evidence of Eczematous Skin Characteristics in Mild Allergic Asthma.

Evidence of Eczematous Skin Characteristics in Mild Allergic Asthma.

Journal: Clinical and translational allergy

Published: June 10, 2025

Predicting airway hyperresponsiveness to methacholine in patients with atopic dermatitis.

Predicting airway hyperresponsiveness to methacholine in patients with atopic dermatitis.

Journal: The journal of allergy and clinical immunology. Global

Published: June 06, 2025

Immune Response Dynamics and Biomarkers in COVID-19 Patients.

Immune Response Dynamics and Biomarkers in COVID-19 Patients.

Journal: International journal of molecular sciences

Published: May 15, 2024

Gene Polymorphisms of Epithelial Cell-Derived Alarmins and Their Effects on Protein Levels and Disease Severity in Patients with COVID-19.

Gene Polymorphisms of Epithelial Cell-Derived Alarmins and Their Effects on Protein Levels and Disease Severity in Patients with COVID-19.

Journal: Genes

Published: July 31, 2023

Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.

Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: February 09, 2023

Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma.

Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma.

Journal: Allergy

Published: July 13, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026